OCT 11, 2016 12:32 PM PDT

How Epstein-Barr Virus Evades the Immune System

WRITTEN BY: Kara Marker
The Epstein-Barr Virus (EBV), infamously known for causing bouts of mononucleosis, was originally discovered in 1964 in tissue from a Burkitt lymphoma tumor. Whether it is a college student dealing with an incapacitating mono infection or another individual dealing with a serious EBV-related tumor growth, the virus has a way of exacerbating these conditions by evading the immune system, and scientists are swiftly figuring out how to prevent it from doing so. 
The Epstein-Barr virus prevents infected cells from being attacked by the immune system.
From Helmholtz Zentrum München, the German Research Center for Environmental Health, scientists studied how EBV particles take over B lymphocytes and force them to proliferate without warning other immune cells of the EBV infection. They found that the viral particles produce microRNAs that prevent the normal alarm signal that is sent out by an infected B lymphocyte, so other immune cells could pass by with no reason to believe that the infected cell was under any duress.

"The mechanism we discovered renders killer T cells and helper T cells inactive, even when they directly face the infected cell," said study leader Wolfgang Hammerschmidt.

Normally, infected cells signal to the immune system via molecular pieces of the virus infected them on the cell surface for all to see. However, EBV-associated microRNAs block the production of the proteins required for putting this alert response into action.

"If it were possible to disrupt this blockade, this could be an interesting approach to treat cancer,” Hammerschmidt explained. “The immune system could then better fight tumors that are triggered by EBV."

EBV, also known as human herpesvirus 4, is actually commonly spread among humans through bodily fluids, most often saliva, which is why some refer to mononucleosis as “the kissing disease.” The Centers for Disease Control and Prevention states that most people get infected with EBV at some point in their lives, but usually a healthy immune system can keep an infection at bay.

In addition to targeting cases of mononucleosis, which has no specific treatment options, Hammerschmidt’s findings could be also be helpful in treating EBV-related cases of cancer. EBV was the first virus to be shown to cause cancer in humans, and it is associated with a wide variation of human cancers. 

Hammerschmidt’s study was recently published in the journal Proceedings of the National Academy of Sciences.
 


Sources: CDC, Experimental and Molecular Medicine, Helmholtz Zentrum München
Image: Prof. Georg Bornkamm / Helmholtz Zentrum München
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 04, 2018
Immunology
JUN 04, 2018
Asthma and Flu Make A Deadly Combination
When someone with a cold or the flu also has an asthma attack, the situation can become life-threatening very quickly. From the University of Montreal, sci...
JUN 11, 2018
Immunology
JUN 11, 2018
Post-Trauma Treatment Relieves System-Wide Immune Reaction
The immune response after a traumatic physical injury is essentially the same as a body-wide bacterial infection: inflammatory, systemic, and lethal. From...
JUL 04, 2018
Microbiology
JUL 04, 2018
Revealing How Gut Bacteria can Impact our Health
Our GI tract pays host to trillions of microbes, which have been shown to play a highly influential role in our health and well-being....
JUL 05, 2018
Health & Medicine
JUL 05, 2018
Is Testing Everyone for Hep C Necessary?
Cases of Hepatitis C, known as Hep C or HCV, are on the rise. In the United States, the CDC reports that there were approximately 3,000 new cases of hepati...
AUG 27, 2018
Immunology
AUG 27, 2018
Undiscovered Tunnels from Bone Marrow To Brain
Newly discovered tunnels connect bone marrow of the skull directly to lining of the brain to allow for quick access of immune cells to brain damaged tissues....
SEP 04, 2018
Immunology
SEP 04, 2018
Development of Damaging Immune Cells in Tuberculosis Infection
Development of damaging white blood cells occurs during Tuberculosis infection leading to a maladaptive immune response....
Loading Comments...